Evaluation of the safety and immunogenicity of two fractional intradermal regimens of MVA-BN compared to standard dose vaccination. Frey SE, Baden LR, El Sahly HM, Davey RT, et al. Vaccine 2025;69:127959.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Frey SE, Baden LR, El Sahly HM, Davey RT, et al. Evaluation of the safety and immunogenicity of two fractional intradermal regimens of MVA-BN compared to standard dose vaccination. Vaccine 2025;69:127959.
PMID: 41319397